DK0556393T3 - Tilkondenseret pyrazinderivat - Google Patents

Tilkondenseret pyrazinderivat

Info

Publication number
DK0556393T3
DK0556393T3 DK91918943T DK91918943T DK0556393T3 DK 0556393 T3 DK0556393 T3 DK 0556393T3 DK 91918943 T DK91918943 T DK 91918943T DK 91918943 T DK91918943 T DK 91918943T DK 0556393 T3 DK0556393 T3 DK 0556393T3
Authority
DK
Denmark
Prior art keywords
represent
alkyl
pyrazine derivative
nitro
cycloalkyl
Prior art date
Application number
DK91918943T
Other languages
English (en)
Inventor
Shuichi Sakamoto
Jun-Ya Ohmori
Hirokazu Kubota
Masao Sasamata
Masamichi Okada
Kazuyuki Hidaka
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Application granted granted Critical
Publication of DK0556393T3 publication Critical patent/DK0556393T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
DK91918943T 1990-11-06 1991-11-01 Tilkondenseret pyrazinderivat DK0556393T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP30087990 1990-11-06
JP6959291 1991-01-11
JP13382891 1991-03-29
JP18324891 1991-06-27
PCT/JP1991/001498 WO1992007847A1 (en) 1990-11-06 1991-11-01 Fused pyrazine derivative

Publications (1)

Publication Number Publication Date
DK0556393T3 true DK0556393T3 (da) 2000-10-16

Family

ID=27465151

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91918943T DK0556393T3 (da) 1990-11-06 1991-11-01 Tilkondenseret pyrazinderivat

Country Status (14)

Country Link
US (1) US5283244A (da)
EP (1) EP0556393B1 (da)
JP (1) JP2550456B2 (da)
KR (1) KR0132903B1 (da)
AT (1) ATE194985T1 (da)
AU (1) AU656154B2 (da)
CA (1) CA2095444C (da)
DE (1) DE69132340T2 (da)
DK (1) DK0556393T3 (da)
ES (1) ES2150417T3 (da)
GR (1) GR3034629T3 (da)
HU (2) HU221425B (da)
RU (1) RU2095352C1 (da)
WO (1) WO1992007847A1 (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK162491D0 (da) * 1991-09-20 1991-09-20 Novo Nordisk As Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne
US6057304A (en) 1992-10-26 2000-05-02 Schering Aktiengesellschaft Quinoxaline-phosphonic acid derivatives
DE4217952A1 (de) * 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
WO1994000124A1 (en) * 1992-06-22 1994-01-06 Eckard Weber Glycine receptor antagonists and the use thereof
EP0664807B1 (en) 1992-10-13 1997-09-10 Warner-Lambert Company Quinoxalinedione derivatives as eaa antagonists
PH31122A (en) * 1993-03-31 1998-02-23 Eisai Co Ltd Nitrogen-containing fused-heterocycle compounds.
IL109397A0 (en) * 1993-04-28 1994-07-31 Schering Ag Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
US5631373A (en) * 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
DE4340045A1 (de) * 1993-11-24 1995-06-01 Basf Ag Neue Chinoxaline und Arzneimittel daraus
US5620978A (en) * 1994-01-03 1997-04-15 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor
AU688459B2 (en) * 1994-04-08 1998-03-12 Shionogi & Co., Ltd. Oxopyridinylquinoxaline derivative
DE4428152A1 (de) * 1994-06-22 1996-01-04 Basf Ag Neue Amido-chinoxalindione, ihrer Herstellung und Verwendung
GB9419318D0 (en) * 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
US6096743A (en) * 1994-09-27 2000-08-01 Yamanouchi Pharmaceuticals Co., Ltd. 1,2,3,4-tetrahydroquinoxalinedione derivative
DE4436852A1 (de) * 1994-10-14 1996-04-18 Basf Ag Pyrrolyl-tetrahydrobenzochinoxalindione, ihre Herstellung und Verwendung
US5801183A (en) * 1995-01-27 1998-09-01 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Aza and aza (N-oxy) analogs of glycine/NMDA receptor antagonists
US6110911A (en) * 1995-06-07 2000-08-29 Warner-Lambert Company Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
DE19521058A1 (de) * 1995-06-09 1996-12-12 Basf Ag Verfahren zur Herstellung von Aromaten enthaltenden Polyetherpolyolen
DE19532050A1 (de) * 1995-08-31 1997-03-06 Basf Ag Pyrrolyl-tetrahydrochinoxalindione, ihre Herstellung und Verwendung zur Bekämpfung von Krankheiten
GB9605027D0 (en) * 1996-03-09 1996-05-08 Pfizer Ltd Quinoxalinediones
ZA973884B (en) 1996-05-23 1998-11-06 Du Pont Merck Pharma Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
TW448171B (en) * 1996-06-06 2001-08-01 Yamanouchi Pharma Co Ltd Imidazole-substituted quinoxalinedione derivatives
US5824662A (en) * 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
DE19624808A1 (de) 1996-06-21 1998-01-02 Basf Ag Pyrrolylchinoxalindione, ihre Herstellung und Verwendung
HUP0001062A3 (en) 1996-09-27 2001-09-28 Guilford Pharmaceuticals Inc B Pharmaceutical compositions of phosphinic acid derivatives having naaladase inhibitor acivity
PT934326E (pt) * 1996-10-24 2006-08-31 Novartis Ag Acidos aminoalcanofosfonicos substituidos
AP982A (en) * 1997-02-27 2001-07-16 Pfizer Quinoxalinediones.
CA2281580C (en) * 1997-02-27 2003-04-22 Pfizer Inc. Quinoxalinediones
TW403740B (en) 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
US6015800A (en) * 1997-09-03 2000-01-18 Warner-Lambert Company Substituted quinoxaline-2-ones as glutamate receptor antagonists
AU9651198A (en) 1997-11-11 1999-05-31 Ono Pharmaceutical Co. Ltd. Fused pyrazine compounds
WO2001055110A1 (en) * 2000-01-24 2001-08-02 Neurosearch A/S Isatine derivatives with neurotrophic activity
JP5237798B2 (ja) 2005-06-23 2013-07-17 アレイ バイオファーマ、インコーポレイテッド ベンズイミダゾール化合物の調製方法
ATE513831T1 (de) * 2006-04-21 2011-07-15 Pfizer Prod Inc Pyridinä3,4-büpyrazinone
US7601716B2 (en) * 2006-05-01 2009-10-13 Cephalon, Inc. Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
CN101595100B (zh) 2007-01-16 2014-06-11 普渡制药公司 作为orl-1配体的杂环取代的哌啶
EP2150248A4 (en) 2007-01-16 2011-06-29 Univ Johns Hopkins GLUTAMATE RECEPTOR ANTAGONISTS AND METHODS OF USE
EP3564240B1 (en) * 2007-08-31 2022-04-06 Purdue Pharma L.P. Piperidine intermediates
WO2010053757A1 (en) 2008-10-29 2010-05-14 Gilead Palo Alto, Inc. 2 -oxoquinoxalin blockers of the late sodium channel
WO2010074807A1 (en) 2008-10-30 2010-07-01 Gilead Palo Alto, Inc. 3, 4-dihydroquinolin-2 ( 1h ) -one derivatives as sodium channel modulators
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer
WO2023042888A1 (ja) 2021-09-15 2023-03-23 国立大学法人 琉球大学 認知機能低下、または過体重もしくは肥満症を処置することに用いるための医薬組成物
WO2023042887A1 (ja) 2021-09-15 2023-03-23 国立大学法人 琉球大学 認知機能低下、または過体重もしくは肥満症を処置することに用いるための医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE66149B1 (en) * 1986-09-16 1995-12-13 Novo Nordisk As Quinoxaline compounds and their preparation and use
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
CA2002864C (en) * 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
GB8827822D0 (en) * 1988-11-29 1988-12-29 Janssen Pharmaceutica Nv (1h-azol-1-ylmethyl)substituted quinoline derivatives
DK715888D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse

Also Published As

Publication number Publication date
KR0132903B1 (ko) 1998-04-17
ATE194985T1 (de) 2000-08-15
DE69132340T2 (de) 2001-02-08
HU9301298D0 (en) 1993-09-28
DE69132340D1 (de) 2000-08-31
RU2095352C1 (ru) 1997-11-10
JP2550456B2 (ja) 1996-11-06
EP0556393B1 (en) 2000-07-26
EP0556393A4 (en) 1994-04-13
US5283244A (en) 1994-02-01
CA2095444A1 (en) 1992-05-07
HU221425B (en) 2002-10-28
EP0556393A1 (en) 1993-08-25
GR3034629T3 (en) 2001-01-31
HU211310A9 (en) 1995-11-28
AU8766691A (en) 1992-05-26
CA2095444C (en) 2001-06-19
HUT64324A (en) 1993-12-28
ES2150417T3 (es) 2000-12-01
AU656154B2 (en) 1995-01-27
WO1992007847A1 (en) 1992-05-14

Similar Documents

Publication Publication Date Title
ATE194985T1 (de) Kondensiertes pyrazinderivat
IL97403A0 (en) 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones,oxazolidinones,and imidazolidinones and pharmaceutical compositions containing them
DE68920556T2 (de) Substituierte Thiazole und ihre Anwendung als Fungizide.
ES2088537T3 (es) Derivados de piranil cianoguanidina.
ES2161713T3 (es) Derivado de metotrexato.
ES2110213T3 (es) Derivado de n-acilglutamina.
DK0591058T3 (da) Ellipticinderivater med antitumoraktivitet
ATE210642T1 (de) 2-substituierte vitamin-d3-derivate
DK451389D0 (da) 2-substituerede 4,5-diaryl-thioimidazoler samt farmaceutisk praeparat indeholdende saadanne forbindelser
DE69426620D1 (de) Antidepressiva
DK0623131T3 (da) Alkylderivater af trazodon med CNS-aktivitet
ATE84303T1 (de) Cysteinderivate.
DK0658555T3 (da) Pyridazinonderivater, fremgangsmåder til fremstilling deraf samt anvendelse deraf
ATE177106T1 (de) Ymidothiophosphat-derivat und insektizid, nematozid und akarizid enthalted dasselbe als aktiven bestandteil.
DE60316219D1 (de) Farbphotographisches lichtempfindliches Silberhalogenidmaterial
PL324070A1 (en) Novel compounds of ellipticin, method of obtaining them and pharmaceutical preparations containing such compounds